ArticleMolecular pharmacology2019
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax.
Smit Kour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleMolecular pharmacology2019
Smit Kour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.